Reply

[...]they state that there were no comparative data referring to the demographics and baseline ocular characteristics of patients treated with dexamethasone implant and injections of a vascular endothelial growth factor (VEGF)-neutralizing protein. [...]they question if the 2 groups were comparable,...

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology 2016-10, Vol.170, p.245
Main Authors: Campochiaro, Peter A, Hafiz, Gulnar, Mir, Tahreem A, Scott, Adrienne W, Zimmer-Galler, Ingrid, Shah, Syed M, Wenick, Adam S, Brady, Christopher J, Han, Ian, He, Lingmin, Channa, Roomasa, Poon, David, Meyerle, Catherine, Aronow, Mary Beth, Sodhi, Akrit, Handa, James T, Kherani, Saleema, Han, Yong, Sophie, Raafay, Wang, Guohua, Qian, Jiang
Format: Article
Language:English
Subjects:
Edema
Permeability
Proteins
Vascular endothelial growth factor
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]they state that there were no comparative data referring to the demographics and baseline ocular characteristics of patients treated with dexamethasone implant and injections of a vascular endothelial growth factor (VEGF)-neutralizing protein. [...]they question if the 2 groups were comparable, but the comparison is between 2 treatments given to the same patient population, so comparability among groups is not an issue.
ISSN:0002-9394
1879-1891
DOI:10.1016/j.ajo.2016.07.014